NASDAQ:TSVT
2seventy bio, Inc. Stock Company Profile
$4.96
+0.0100 (+0.202%)
At Close: May 07, 2024
Information
60 Binney Street
Cambridge MA 02142
339 499 9300
www.2seventybio.com
Industry: Biotechnology
Sector: Healthcare
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
